Michael Rudnicki - Satellos Bioscience CoFounder Officer
| MSCLF Stock | USD 0.48 0.02 4.00% |
Insider
Michael Rudnicki is CoFounder Officer of Satellos Bioscience
| Age | 62 |
| Phone | 647 660 1780 |
| Web | https://satellos.com |
Satellos Bioscience Management Efficiency
The company has return on total asset (ROA) of (0.3953) % which means that it has lost $0.3953 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.8596) %, meaning that it generated substantial loss on money invested by shareholders. Satellos Bioscience's management efficiency ratios could be used to measure how well Satellos Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| MS MD | Paradigm Biopharmaceuticals Lim | 66 | |
| Beverley Huttmann | Paradigm Biopharmaceuticals Lim | N/A | |
| Nathan CA | Imugene Limited | N/A | |
| Ravi Krishnan | Paradigm Biopharmaceuticals Lim | N/A | |
| BSc BVSc | Starpharma Holdings | 59 | |
| Mukesh Ahuja | Paradigm Biopharmaceuticals Lim | N/A | |
| Larry Jones | Biostem Technologies | N/A | |
| Grad BSc | Paradigm Biopharmaceuticals Lim | 64 | |
| Justin Cahill | Paradigm Biopharmaceuticals Lim | N/A | |
| Michael Imperiale | Paradigm Biopharmaceuticals Lim | N/A | |
| Wai FCS | Kintor Pharmaceutical Limited | 68 | |
| Yan Lu | Kintor Pharmaceutical Limited | 40 | |
| Grad BCom | Starpharma Holdings | N/A | |
| ChengHsiang Kao | VitaSpring Biomedical Co | N/A | |
| ACA BSc | Imugene Limited | 56 | |
| Dr BSc | Imugene Limited | N/A | |
| CheLi Lin | VitaSpring Biomedical Co | N/A | |
| Marco Polizzi | Paradigm Biopharmaceuticals Lim | N/A | |
| Simon White | Paradigm Biopharmaceuticals Lim | N/A | |
| Youzhi Tong | Kintor Pharmaceutical Limited | 60 | |
| YenHsun Chen | VitaSpring Biomedical Co | N/A | |
Management Performance
| Return On Equity | -0.86 | |||
| Return On Asset | -0.4 |
Satellos Bioscience Leadership Team
Elected by the shareholders, the Satellos Bioscience's board of directors comprises two types of representatives: Satellos Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Satellos. The board's role is to monitor Satellos Bioscience's management team and ensure that shareholders' interests are well served. Satellos Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Satellos Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Rudnicki, CoFounder Officer | ||
| CPA CMA, Chief Officer | ||
| Philip MA, Chief Officer | ||
| Robert CFA, VP Admin | ||
| Francis MBA, CEO, CoFounder | ||
| William Jarosz, Ex Director | ||
| Bsc BSc, Strategic Advisor |
Satellos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Satellos Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.86 | |||
| Return On Asset | -0.4 | |||
| Current Valuation | 7.17 M | |||
| Shares Outstanding | 41.8 M | |||
| Shares Owned By Insiders | 9.30 % | |||
| Shares Owned By Institutions | 14.41 % | |||
| Price To Book | 1.10 X | |||
| Price To Sales | 295.34 X | |||
| Gross Profit | (793.97 K) | |||
| EBITDA | (4.49 M) |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Satellos OTC Stock
Satellos Bioscience financial ratios help investors to determine whether Satellos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.